Friday, October 6, 2017

Easing the menopause transition by latest technology- upcoming North American Menopause Society (NAMS) 2017 Annual Meeting.


The upcoming NAMS 2017 annual meeting that will be held at Philadelphia October 11-14 is sure to be an academic feast. The scientific session will bring in all the latest and comprehensive updates from world renowned speakers with focus on the technological advances that can help women in seemingly smooth transition through the menopausal years.

The meeting is going to kick start with a pre-meeting symposium about Musculoskeletal Health in Postmenopausal Women: Assessment and Management of Fracture Risk by Co-Chair, Michael R. McClung, MD.  This symposium will cover assessment of postmenopausal osteoporosis; including dual-energy x-ray absorptiometry(DXA) best practices and new imaging modalities. It will also cover the new pharmacological therapies for osteoporosis and ways to improve the muscle functions.

This will be followed by President’s Reception and other CME activities. The topics that are expected to be covered include: Vaginal Health and Pelvic Pain, Hormone Therapy, Uterine Bleeding and Adnexal Masses, Lesbian Health and Sexuality, Cardiovascular Disease Risk Factors, Migraines and Mood Disorders in Midlife Women, Advances in Breast Imaging, Musculoskeletal Health Concerns, Social Media and Technology: Driving the Direction of Women’s Health and Update on MsFLASH Trials.

The NAMS updated position statement on Hormone therapy will be presented by JoAnn Pinkerton, MD, from the University of Virginia in Charlottesville, who is executive director of NAMS.
The findings of WHI follow -up study published in JAMA, played a key role in supporting some of the recommendations.

Technological advances, especially mobile health technology and its role in improving patient’s engagement and health will also be focused upon.

In all, the meeting will engage a diverse, multiracial, multiethnic and multispecialty group of people with varied interests, but there will be something for everyone.

Looking forward seeing latest updates and good clinical research abstracts from the meeting.

Related Links




No comments:

Post a Comment